Richard Pops

Richard Pops

Chief Executive Officer at ALKERMES PLC

Net worth: 64 M $ as of 31/05/2026

64 year
Health Technology
Commercial Services
Consumer Services

Profile

Richard F. Pops founded Sirtris Pharmaceuticals, Inc. Presently, he is Chairman & Chief Executive Officer of Alkermes Plc and Chairman & Chief Executive Officer for Alkermes, Inc. (a subsidiary of Alkermes Plc). He is also on the board of Neurocrine Biosciences, Inc., Biotechnology Innovation Organization and Pharmaceutical Research & Manufacturers of America. Mr. Pops previously held the position of Strategic Advisor at Longwood Fund Management LLC, Member-Board Fellows at Harvard Medical School and Director at Sirtris Pharmaceuticals, Inc. Mr. Pops received an undergraduate degree from Stanford University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/03/2026 1,377,740 ( 0.83% ) 58 M $ 31/05/2026
27/05/2026 37,798 ( 0.04% ) 6 M $ 31/05/2026

Richard Pops active positions

CompaniesPositionStart
NEUROCRINE BIOSCIENCES, INC. Director/Board Member 01/04/1998
ALKERMES PLC Chief Executive Officer 01/02/1991
Director/Board Member -
Chief Executive Officer 01/01/1991
Director/Board Member -

Former positions of Richard Pops

CompaniesPositionEnd
EPIZYME, INC. Director/Board Member 31/10/2020
ACCELERON PHARMA INC. Director/Board Member 31/12/2019
Director/Board Member 10/12/2019
Corporate Officer/Principal 01/06/2012
░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Richard Pops's experience

Training of Richard Pops

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

17

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies17

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Consumer Services

Finance

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!